Clinical Diagnostics
anyTarget: Diagnostic Laboratories
If you are a diagnostic lab dealing with expensive and slow microbiome testing — this project developed MICK, a digital platform that reduces costs by up to 75% and speeds up turnaround times.
MICK · Project
Automated Microbiome Analysis Platform for Clinical Diagnostics and Personalized Patient Care
healthMarket-readyTRL 9
Imagine your body is like a garden with trillions of tiny bugs. When the garden gets out of balance, you get sick. This tool acts like an automated gardener that quickly scans these bugs and tells doctors exactly how to fix the balance to keep patients healthy.
By the numbers
75%
cost reduction compared to existing solutions
The business problem
What needed solving
Microbiome analysis is currently too complex, expensive, and slow for routine clinical use. Doctors cannot use it because it requires specialized bioinformatics knowledge and expensive IT infrastructure.
The solution
What was built
A digital decision support platform (MICK) that automates raw microbiome data analysis and provides evidence-based treatment recommendations.
Audience
Who needs this
Diagnostic LaboratoriesClinical CentersPathology LabsPreventive Healthcare Providers
Business applications
Who can put this to work
Healthcare Providers
SMETarget: Private Clinical Centers
If you are a clinical center dealing with the lack of bioinformatics experts to interpret gut health data — this project developed an automated system that translates raw sequencing data into treatment suggestions without needing coding skills.
Infectious Disease Management
mid-sizeTarget: Specialized Pathology Labs
If you are a pathology lab dealing with the difficulty of identifying dangerous pathogens — this project developed an IVDR module that allows for the accurate identification of Class B pathogens.
Frequently asked
Quick answers
How does this affect the cost of microbiome testing?
Based on available project data, the platform allows customers to determine up to a 75% cost reduction compared to existing solutions.
Can this be scaled for industrial use in labs?
Yes, MICK is designed as a digital decision support system that allows clinical centers and labs to scale their service offering to patients without upfront investment.
What is the IP or licensing status?
Based on available project data, the platform is branded as MICK©, indicating a protected intellectual property asset owned by Sequentia Biotech SL.
Does the system comply with medical regulations?
The project includes an IVDR module specifically for the accurate identification of Class B pathogens, suggesting alignment with In Vitro Diagnostic Regulations.
How is the platform integrated into existing workflows?
MICK operates across different sequencing technologies and automates workflows to eliminate the need for advanced bioinformatics expertise or specialized IT infrastructure.
Consortium
Who built it
The project is led by a single Spanish SME, Sequentia Biotech SL. With a 100% industry ratio and no university or research partners, the project was focused entirely on commercial delivery and market application rather than academic exploration.
How to reach the team
Contact Sequentia Biotech SL in Spain for licensing or partnership inquiries.
Next steps
Talk to the team behind this work.
Contact us to find similar AI-driven diagnostic platforms for clinical integration.
More in Health & Biomedical
See all Health & Biomedical projects →